Paris, France et Camberley, Royaume-Uni – 1 juillet 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), un spécialiste international du diagnostic clinique, publie aujourd’hui le bilan mensuel du nombre d’actions échangées au titre du contrat de liquidité confié à Invest Securities SA (le « Contrat de liquidité »). http://novacyt.com/wp-content/uploads/2019/07/Contrat-de-liquidité-1-juillet-2019.
Visit PageCategory: Board
Liquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). http://novacyt.com/wp-content/uploads/2019/07/Liquidity-Agreement-1-July-2019.pdf
Visit PageLiquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 July 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit Page